Today in Seminole County, Florida, a new technology named ‘Drug Alert AI’ was introduced to help address the drug crisis by ...
Pharmaceutical Technology on MSN
Debiopharm and NetTargets to identify synergistic drug combos for ADCs
NetTargets employs an AI system that combines multi-omics data with neural network modelling for drug discovery.
Scientists from King's College London have successfully applied a new technology that disarms one of the most potent weapons ...
Over the last four or five years, while teaching pharmacology to students during his graduate program at UC Santa Barbara, doctoral candidate Willus Fisher noted a persistent problem. “Every year, I ...
SandboxAQ, a U.S.-based artificial intelligence and quantum technology firm, signed an agreement with Bahrain's sovereign ...
React4Life’s Silvia Scaglione emphasizes how organ-on-chip tech and AI are reshaping drug testing, personalized treatment, ...
The U.S. Food and Drug Administration (FDA) has issued draft guidance on its “Platform Technology Designation Program,” which aims to streamline drug development, manufacturing, and marketing ...
DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.
GlobalData on MSN
MapLight’s $251m IPO sees schizophrenia drug developers on top
Illuminating its plans, neurological disease specialist MapLight said it would offer 14,750,000 shares of its common stock at $17.00 per share, which works out to an IPO of around $251m. The biotech ...
A portable device that can instantly detect dangerous street drugs at extremely low concentrations has been developed at the University of Bath in the UK. The device, which is being trialled by ...
The lifting of the FDA’s clinical hold on Neurizon’s drug will pave the way for its investigation in the HEALEY-ALS trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results